Keywords: راش; Afatinib; Rash; Minocycline; Tetracycline; Epidermal growth factor inhibitor;
مقالات ISI راش (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: راش; Chikungunya; dengue; fever; MRCP; rash; rickettsiae; travel; Zika;
Keywords: راش; Skin rash; Exanthema; Fever; Skin lesion; Rash; Erupción cutánea; Exantema; Fiebre; Lesión cutánea; Rash;
Keywords: راش; infection; toxic shock syndrome; Staphylococcus aureus; Streptococcus pyogenes; toxin; fever; hypotension; rash; erythroderma; desquamation;
Keywords: راش; fever; petechiae; rash; Rocky Mountain spotted fever; tick; tick-borne; vasculitis;
Keywords: راش; autoimmune; connective tissue disease; Ehlers-Danlos syndrome; Marfan syndrome; pregnancy; pruritus; rash; systemic lupus erythematosis;
Keywords: راش; Childhood; erythema infectiosum; exanthem; measles; MRCP; rash; rubella; varicella;
Keywords: راش; CMCC; chronic mucocutaneous candidiasis; DOCK8; dedicator of cytokinesis 8; ER; emergency room; VZV; varicella zoster virus; Curriculum development; Dermatology; Emergency care; Pediatrics; Primary care education; Rash;
Keywords: راش; Dermatitis; Rash; Breast reconstruction; Breast cancer; Topical corticosteroids;
Keywords: راش; Erythema migrans; Lyme disease; Rash; STARI; Tick bites;
Keywords: راش; Head and neck cancer; Radiotherapy; Cetuximab; Dermatitis; Rash;
Keywords: راش; rash; petechiae; purpura; vesiculobullous; erythema; maculopapular;
Keywords: راش; Mycoplasma pneumoniae; Erythema multiforme; Stevens-Johnson syndrome; Rash; Mucositis; Clinical classification; TreatmentMycoplasma pneumoniae; Eritema multiforme; Síndrome de Stevens-Johnson; Exantema; Mucositis; Clasificación clínica; Tratamiento
Keywords: راش; Cellulitis; Kaposi's sarcoma; Lymphedema; Rash; Nodule;
Keywords: راش; Treprostinil; Pulmonary hypertension; Eosinophilia; Rash;
Keywords: راش; autoimmune; connective tissue disease; Ehler-Danlos syndrome; Marfan's syndrome; pregnancy; pruritis; rash; systemic lupus erythematosis
Keywords: راش; Lamotrigine; Rash; Incidence; Prospective study; Meta-analysis
Keywords: راش; Epidermal growth factor inhibitors; Monoclonal antibodies (cetuximab, panitumumab); Adverse drug reaction; Rash; Clinical markers; Tumor responseInhibidores del factor de crecimiento epidérmico; Anticuerpos monoclonales (cetuximab, panitumumab); Reacción
Keywords: راش; erythema multiforme; mucositis; Mycoplasma pneumoniae; rash; Stevens-Johnson syndrome; IVIG; intravenous immunoglobulin; MIRM; Mycoplasma-induced rash and mucositis; SJS; Stevens-Johnson syndrome; TEN; toxic epidermal necrolysis;
Keywords: راش; Measles elimination; Vaccine preventable; Vaccination; Exemptions; Mortality; Rash; Fever;
Keywords: راش; chikungunya; dengue; fever; infectious mononucleosis; rash; rickettsiae; travel
Keywords: راش; erythema infectiosum; exanthem; measles; rash; roseola; rubella; varicella; virus;
Keywords: راش; desensitization; oxcarbazepine; children; rash; human leukocyte antigen; drug allergy;
Keywords: راش; cancer therapy; chemotherapy; cutaneous reactions; drug hypersensitivity; rash; target drugs; EGFR; epidermal growth factor receptor; EGFRI; epidermal growth factor receptor inhibitor; HFSR; hand-foot skin reaction; IRAE; immune-related adverse event; M
Keywords: راش; cancer; chemotherapy; cutaneous reactions; cytotoxic therapy; drug hypersensitivity; rash; 5-FU; 5-flurouracil; CLL; chronic lymphocytic leukemia; HFS; hand-foot syndrome; NHL; non-Hodgkin lymphoma; NSCLC; non-small cell lung carcinoma;
Keywords: راش; Rickettsioses; Syndrome; Arthropod-borne diseases; Rickettsia spp.; Rash; Eschar
Keywords: راش; Epilepsy; Levetiracetam; Cutaneous adverse drug reactions; Rash; Human leukocyte antigen
“Treating Through” Decision and Follow-up in Antibiotic Therapy-Associated Exanthemas
Keywords: راش; Desensitization; Drug reaction; Adverse drug reaction; Allergy; Hypersensitivity; Rash; Rechallenge; DIHS; Drug-induced hypersensitivity syndrome; MPE; Maculopapular exanthema;
ANXA1Ac2-26 peptide, a possible therapeutic approach in inflammatory ocular diseases
Keywords: راش; ACTB; Beta-actin; ALDH1A3; Aldehyde Dehydrogenase 1 Family, member A3; ANX; Annexin; ANXA1; Annexin A1; ANXA1Ac2-26; peptide of the ANXA1; ARPE-19; human retinal pigment epithelium cells; BRB; blood retinal barrier; CTGF; Connective Tissue Growth Factor
Recurrent Subepidermal Blistering Dermatosis Heralding Disease Relapse in IgA Kappa Multiple Myeloma: Report of a Case and a Review of the Literature
Keywords: راش; Bullous disease; IgA kappa; Paraneoplastic; Paraproteinemia; Rash;
Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer: A Case Series Analysis
Keywords: راش; Adjuvant; HER2+; Lapatinib; Rash; Toxicity;
Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial
Keywords: راش; doxycycline; erlotinib; folliculitis; non-small-cell lung cancer; rash; AE; adverse event; CI; confidence interval; CONSORT; CONsolidated Standards Of Reporting Trials; CTCAE; Common Terminology Criteria for Adverse Events; CYTAR; CYcline and TARceva; DI;
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
Keywords: راش; Adverse events; Immune-checkpoint; Immunotherapy; Nivolumab; PD-1; Pembrolizumab; Programmed death-1; Pruritus; Rash; Vitiligo;
Kikuchi Fujimoto disease
Keywords: راش; Kikuchi Fujimoto disease; Cervical lymphadenopathy fever; Rash; Arthralgia
ANXA1Ac2-26 peptide reduces ID1 expression in cervical carcinoma cultures
Keywords: راش; [LaCit2]3; lanthanum citrate complex; μg; microgram; ACTB; beta-actin; ANX; annexin; ANXA1; annexin A1; BMP4; bone morphogenetic protein 4; BMPR1B; bone morphogenetic protein receptor, type IB; cDNA; complementary DNA; CO2; carbon dioxide; DNA; deoxyribo
Factores predictores de respuesta y revisión de la toxicidad cutánea de cetuximab y panitumumab en 116 pacientes
Keywords: راش; Inhibidores del factor de crecimiento epidérmico; Anticuerpos monoclonales (cetuximab, panitumumab); Reacción adversa medicamentosa; Erupción cutánea; Marcadores clÃnicos; Respuesta tumoral; Epidermal growth factor inhibitors; Monoclonal antibodies (
Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United States
Keywords: راش; anemia; CHC; cost; DAA; rash; resource utilization;
Diagnosis and classification of adult Still's disease
Keywords: راش; Still's disease; Fever; Arthritis; Rash; fever of unknown origin; Cytokines
Diagnostic précoce du syndrome APECEDÂ : un défi pour le dermatologue
Keywords: راش; APECED; Polyendocrinopathie auto-immune de type 1; Ãruption cutanée; Candidose cutanéo-muqueuse; Gène AIRE; Hépatite; Åsophagite; Onychomycose; APECED; Polyglandular auto-immune syndrome type 1; Rash; Mucocutaneous candidiasis; AIRE gene; Hepatitis;
Dermatomyositis
Keywords: راش; cancer; dermatomyositis; myopathy; paraneoplastic; rash
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma
Keywords: راش; cutaneous adverse event; histology; inflammation; rash; squamous cell carcinoma; therapy; AK; actinic keratosis; bid; twice a day; BRAFi; BRAF inhibitor; CI; confidence interval; FDA; Food and Drug Administration; KA; keratoacanthoma; MAPK; mitogen-activa
Ipilimumab in patients with cancer and the management of dermatologic adverse events
Keywords: راش; adverse event management; dermatologic; immune-related; ipilimumab; melanoma; pruritus; rash; vitiligo; AE; adverse event; CTLA; cytotoxic T-lymphocyte antigen; GI; gastrointestinal; irAE; immune-related adverse event;
Adverse Event Management of mTOR Inhibitors During Treatment of Hormone Receptor–Positive Advanced Breast Cancer: Considerations for Oncologists
Keywords: راش; Advanced breast cancer; Adverse events; Everolimus; Infection; mTOR; Noninfectious pneumonitis; Rash; Stomatitis
The risk of rash associated with ipilimumab in patients with cancer: A systematic review of the literature and meta-analysis
Keywords: راش; adverse event; cancer; drug reaction; ipilimumab; melanoma; rash; AE; adverse events; ASCO; American Society of Clinical Oncology; CI; confidence interval; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; FDA; Food and Drug Administration; IL; inter
Rash
Keywords: راش; dermatology; examination; history; investigation; rash; skin biopsy
A 6-Year-Old Girl with Fever, Rash, and Increased Intracranial Pressure
Keywords: راش; Rocky Mountain spotted fever; raised intracranial pressure; fever; rash
Management of anaemia and other treatment complications
Keywords: راش; Anaemia; Hepatitis C; Protease inhibitor; Rash
Risk of Rash Associated With Lenalidomide in Cancer Patients: A Systematic Review of the Literature and Meta-analysis
Keywords: راش; Lenalidomide; Multiple myeloma; Myelodyplastic syndrome; Rash; Skin toxicities
Not Just Another Rash
Keywords: راش; fever; rash; rat-bite fever; Streptobacillus moniliformis
Uso clÃnico de telaprevir: reglas de parada, predicción de la respuesta, duración de la terapia y manejo de los efectos adversos
Keywords: راش; Reglas de parada; Respuesta viral extendida; Exantema; Anemia; Stopping rules; Extended viral response; Rash; Anemia;